Enhancing survival of mouse oocytes following chemotherapy or aging by targeting bax and Rad51

Loro L. Kujjo, Tiina Laine, Ricardo J G Pereira, Wataru Kagawa, Hitoshi Kurumizaka, Shigeyuki Yokoyama, Gloria I. Perez

    Research output: Contribution to journalArticle

    29 Citations (Scopus)

    Abstract

    Background:Therapeutic approaches to preserve fertility in females undergoing cancer treatments are currently ineffective. This is partly due to limited knowledge of the molecular mechanisms that injured germ cells elicit to repair damage and survive or to abort repair and activate biochemical pathways leading to death. So far, we know that following spontaneously occurring or drug-induced DNA damage, the efficiency of DNA repair is a critical determinant of the cell's fate. The protein encoded by the Rad51 gene is one of several components recruited for homologous recombinationdependent DNA double-strand break repair in both somatic cells and germ cells. Recently, we showed that microinjection of recombinant Rad51 into AKR/J mouse oocytes decreased the extent of spontaneous DNA double-strand breaks, suppressed apoptosis, and restored the developmental competence in AKR/J embryos. Herein we characterized the nature of chemotherapy-induced lesions in oocytes, and the associated individual components of the DNA damage sensor and repair apparatus. For comparison, we also assessed parallel spontaneous changes in aging oocytes. Methods: Data collected were derived from: analysis of apoptosis; immunodepletion; oocyte microinjections; immunocytochemistry; immunofluorescence; and CHIP-like assays. Results:Our data show that: (i) DNA damage in oocytes can be induced by both chemotherapy and spontaneously by the aging process; (ii) oocytes possess the machinery and capability for repairing such DNA damage; (iii) Rad51 is a critical player in the repair of both chemotherapy-induced and spontaneously-sustained DNA damage; and (iv) in response to damage, oocytes exhibit an inverse functional relationship between presence of Bax and activity of Rad51. Conclusion/Significance: Our results establish Rad51 and/or Bax as potential candidates that can be targeted for development of individualized chemotherapeutic interventions that are effective, but minimal in toxicity. The use of Rad51 and Bax modulating compounds could offer women the opportunity to maintain fully functional germ cells despite cancer treatments or aging.

    Original languageEnglish
    Article numbere9204
    JournalPLoS One
    Volume5
    Issue number2
    DOIs
    Publication statusPublished - 2010 Feb 12

    Fingerprint

    Chemotherapy
    drug therapy
    Oocytes
    oocytes
    Aging of materials
    DNA damage
    DNA Damage
    Drug Therapy
    Repair
    DNA
    mice
    germ cells
    Double-Stranded DNA Breaks
    Microinjections
    Oncology
    Germ Cells
    Cells
    DNA Repair
    apoptosis
    Inbred AKR Mouse

    ASJC Scopus subject areas

    • Agricultural and Biological Sciences(all)
    • Biochemistry, Genetics and Molecular Biology(all)
    • Medicine(all)

    Cite this

    Kujjo, L. L., Laine, T., Pereira, R. J. G., Kagawa, W., Kurumizaka, H., Yokoyama, S., & Perez, G. I. (2010). Enhancing survival of mouse oocytes following chemotherapy or aging by targeting bax and Rad51. PLoS One, 5(2), [e9204]. https://doi.org/10.1371/journal.pone.0009204

    Enhancing survival of mouse oocytes following chemotherapy or aging by targeting bax and Rad51. / Kujjo, Loro L.; Laine, Tiina; Pereira, Ricardo J G; Kagawa, Wataru; Kurumizaka, Hitoshi; Yokoyama, Shigeyuki; Perez, Gloria I.

    In: PLoS One, Vol. 5, No. 2, e9204, 12.02.2010.

    Research output: Contribution to journalArticle

    Kujjo, LL, Laine, T, Pereira, RJG, Kagawa, W, Kurumizaka, H, Yokoyama, S & Perez, GI 2010, 'Enhancing survival of mouse oocytes following chemotherapy or aging by targeting bax and Rad51', PLoS One, vol. 5, no. 2, e9204. https://doi.org/10.1371/journal.pone.0009204
    Kujjo LL, Laine T, Pereira RJG, Kagawa W, Kurumizaka H, Yokoyama S et al. Enhancing survival of mouse oocytes following chemotherapy or aging by targeting bax and Rad51. PLoS One. 2010 Feb 12;5(2). e9204. https://doi.org/10.1371/journal.pone.0009204
    Kujjo, Loro L. ; Laine, Tiina ; Pereira, Ricardo J G ; Kagawa, Wataru ; Kurumizaka, Hitoshi ; Yokoyama, Shigeyuki ; Perez, Gloria I. / Enhancing survival of mouse oocytes following chemotherapy or aging by targeting bax and Rad51. In: PLoS One. 2010 ; Vol. 5, No. 2.
    @article{f4a457b7e5eb4742a330a7b4c1a6df7a,
    title = "Enhancing survival of mouse oocytes following chemotherapy or aging by targeting bax and Rad51",
    abstract = "Background:Therapeutic approaches to preserve fertility in females undergoing cancer treatments are currently ineffective. This is partly due to limited knowledge of the molecular mechanisms that injured germ cells elicit to repair damage and survive or to abort repair and activate biochemical pathways leading to death. So far, we know that following spontaneously occurring or drug-induced DNA damage, the efficiency of DNA repair is a critical determinant of the cell's fate. The protein encoded by the Rad51 gene is one of several components recruited for homologous recombinationdependent DNA double-strand break repair in both somatic cells and germ cells. Recently, we showed that microinjection of recombinant Rad51 into AKR/J mouse oocytes decreased the extent of spontaneous DNA double-strand breaks, suppressed apoptosis, and restored the developmental competence in AKR/J embryos. Herein we characterized the nature of chemotherapy-induced lesions in oocytes, and the associated individual components of the DNA damage sensor and repair apparatus. For comparison, we also assessed parallel spontaneous changes in aging oocytes. Methods: Data collected were derived from: analysis of apoptosis; immunodepletion; oocyte microinjections; immunocytochemistry; immunofluorescence; and CHIP-like assays. Results:Our data show that: (i) DNA damage in oocytes can be induced by both chemotherapy and spontaneously by the aging process; (ii) oocytes possess the machinery and capability for repairing such DNA damage; (iii) Rad51 is a critical player in the repair of both chemotherapy-induced and spontaneously-sustained DNA damage; and (iv) in response to damage, oocytes exhibit an inverse functional relationship between presence of Bax and activity of Rad51. Conclusion/Significance: Our results establish Rad51 and/or Bax as potential candidates that can be targeted for development of individualized chemotherapeutic interventions that are effective, but minimal in toxicity. The use of Rad51 and Bax modulating compounds could offer women the opportunity to maintain fully functional germ cells despite cancer treatments or aging.",
    author = "Kujjo, {Loro L.} and Tiina Laine and Pereira, {Ricardo J G} and Wataru Kagawa and Hitoshi Kurumizaka and Shigeyuki Yokoyama and Perez, {Gloria I.}",
    year = "2010",
    month = "2",
    day = "12",
    doi = "10.1371/journal.pone.0009204",
    language = "English",
    volume = "5",
    journal = "PLoS One",
    issn = "1932-6203",
    publisher = "Public Library of Science",
    number = "2",

    }

    TY - JOUR

    T1 - Enhancing survival of mouse oocytes following chemotherapy or aging by targeting bax and Rad51

    AU - Kujjo, Loro L.

    AU - Laine, Tiina

    AU - Pereira, Ricardo J G

    AU - Kagawa, Wataru

    AU - Kurumizaka, Hitoshi

    AU - Yokoyama, Shigeyuki

    AU - Perez, Gloria I.

    PY - 2010/2/12

    Y1 - 2010/2/12

    N2 - Background:Therapeutic approaches to preserve fertility in females undergoing cancer treatments are currently ineffective. This is partly due to limited knowledge of the molecular mechanisms that injured germ cells elicit to repair damage and survive or to abort repair and activate biochemical pathways leading to death. So far, we know that following spontaneously occurring or drug-induced DNA damage, the efficiency of DNA repair is a critical determinant of the cell's fate. The protein encoded by the Rad51 gene is one of several components recruited for homologous recombinationdependent DNA double-strand break repair in both somatic cells and germ cells. Recently, we showed that microinjection of recombinant Rad51 into AKR/J mouse oocytes decreased the extent of spontaneous DNA double-strand breaks, suppressed apoptosis, and restored the developmental competence in AKR/J embryos. Herein we characterized the nature of chemotherapy-induced lesions in oocytes, and the associated individual components of the DNA damage sensor and repair apparatus. For comparison, we also assessed parallel spontaneous changes in aging oocytes. Methods: Data collected were derived from: analysis of apoptosis; immunodepletion; oocyte microinjections; immunocytochemistry; immunofluorescence; and CHIP-like assays. Results:Our data show that: (i) DNA damage in oocytes can be induced by both chemotherapy and spontaneously by the aging process; (ii) oocytes possess the machinery and capability for repairing such DNA damage; (iii) Rad51 is a critical player in the repair of both chemotherapy-induced and spontaneously-sustained DNA damage; and (iv) in response to damage, oocytes exhibit an inverse functional relationship between presence of Bax and activity of Rad51. Conclusion/Significance: Our results establish Rad51 and/or Bax as potential candidates that can be targeted for development of individualized chemotherapeutic interventions that are effective, but minimal in toxicity. The use of Rad51 and Bax modulating compounds could offer women the opportunity to maintain fully functional germ cells despite cancer treatments or aging.

    AB - Background:Therapeutic approaches to preserve fertility in females undergoing cancer treatments are currently ineffective. This is partly due to limited knowledge of the molecular mechanisms that injured germ cells elicit to repair damage and survive or to abort repair and activate biochemical pathways leading to death. So far, we know that following spontaneously occurring or drug-induced DNA damage, the efficiency of DNA repair is a critical determinant of the cell's fate. The protein encoded by the Rad51 gene is one of several components recruited for homologous recombinationdependent DNA double-strand break repair in both somatic cells and germ cells. Recently, we showed that microinjection of recombinant Rad51 into AKR/J mouse oocytes decreased the extent of spontaneous DNA double-strand breaks, suppressed apoptosis, and restored the developmental competence in AKR/J embryos. Herein we characterized the nature of chemotherapy-induced lesions in oocytes, and the associated individual components of the DNA damage sensor and repair apparatus. For comparison, we also assessed parallel spontaneous changes in aging oocytes. Methods: Data collected were derived from: analysis of apoptosis; immunodepletion; oocyte microinjections; immunocytochemistry; immunofluorescence; and CHIP-like assays. Results:Our data show that: (i) DNA damage in oocytes can be induced by both chemotherapy and spontaneously by the aging process; (ii) oocytes possess the machinery and capability for repairing such DNA damage; (iii) Rad51 is a critical player in the repair of both chemotherapy-induced and spontaneously-sustained DNA damage; and (iv) in response to damage, oocytes exhibit an inverse functional relationship between presence of Bax and activity of Rad51. Conclusion/Significance: Our results establish Rad51 and/or Bax as potential candidates that can be targeted for development of individualized chemotherapeutic interventions that are effective, but minimal in toxicity. The use of Rad51 and Bax modulating compounds could offer women the opportunity to maintain fully functional germ cells despite cancer treatments or aging.

    UR - http://www.scopus.com/inward/record.url?scp=77950159579&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=77950159579&partnerID=8YFLogxK

    U2 - 10.1371/journal.pone.0009204

    DO - 10.1371/journal.pone.0009204

    M3 - Article

    C2 - 20169201

    AN - SCOPUS:77950159579

    VL - 5

    JO - PLoS One

    JF - PLoS One

    SN - 1932-6203

    IS - 2

    M1 - e9204

    ER -